CIP
CELG

Convergence Investment Partners’s Celgene Corp CELG Stock Holding History

Convergence Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,086
Closed -$1.5M – 344
2019
Q3 		$1.5M Sell
15,086
-1,388
-8% -$132K 0.42% 73
2019
Q2 		$1.52M Sell
16,474
-6,366
-28% -$605K 0.37% 106
2019
Q1 		$2.15M Buy
22,840
+1,332
+6% +$116K 0.47% 67
2018
Q4 		$1.38M Buy
21,508
+4,544
+27% +$335K 0.32% 116
2018
Q3 		$1.52M Buy
+16,964
New +$1.5M 0.31% 126
2018
Q2 		– Sell
-51,008
Closed -$4.55M – 1086
2018
Q1 		$4.55M Buy
+51,008
New +$4.9M 0.59% 35
2017
Q4 		– Sell
-35,534
Closed -$5.18M – 383
2017
Q3 		$5.18M Buy
+35,534
New +$4.84M 0.73% 22
2015
Q4 		– Sell
-99,195
Closed -$10.7M – 425
2015
Q3 		$10.7M Buy
99,195
+2,023
+2% +$251K 1.23% 6
2015
Q2 		$11.2M Buy
97,172
+54,033
+125% +$6.18M 1.11% 9
2015
Q1 		$4.97M Buy
43,139
+25,442
+144% +$3.04M 0.69% 23
2014
Q4 		$1.98M Buy
+17,697
New +$1.87M 0.27% 140

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Convergence Investment Partners's CELG Position: Q4 2019 in Review

Convergence Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,086 shares — an estimated $1.5M sold.

Convergence Investment Partners first reported a position in CELG in Q4 2014 and held it in 11 quarters. The position peaked at $11.2M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Convergence Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 15,086 Celgene Corp shares in Q4 2019, an estimated $1.5M.
  • Convergence Investment Partners first reported a position in Celgene Corp in Q4 2014 and held it in 11 quarters.
  • Convergence Investment Partners's Celgene Corp position peaked at $11.2M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Convergence Investment Partners's 13F filing for Q4 2019, filed 22 Jan 2020.